Join the conversation and let us know what you think.
Kidney360 is the first nephrology journal to launch the commenting tool, Disqus, on its website. Disqus offers an exciting opportunity to engage with authors and other readers.
This new feature is:
- Easy to use: You can comment directly on the article and read the comments of others.
- Available everywhere: Accessible on devices from desktop to mobile.
- Broadly compatible: Supported browsers include Chrome, Edge, Internet Explorer 11, Firefox, Safari 6+.
- Global: Used across the world with 70 languages supported and counting.
The Disqus tool is integrated at the bottom of each article, and the Kidney360 editorial team encourages you to visit the Kidney360 website and begin commenting on the articles.
Before commenting the first time, you will need to sign up for a Disqus account (https://disqus.com/profile/signup/), or you can you can create an account directly through the widget. Simply create a username, and you are ready to start commenting.
If you are interested in following comments, be sure to select “Subscribe” for each individual article. “Subscribe” will enable you to receive notification when comments are added.
The image below shows Disqus at the bottom of a Kidney360 article.
You can learn more about Disqus on their website. If you have any questions about the Code of Conduct for using Disqus, please see https://kidney360.asnjournals.org/page/Commenting.